🚀 VC round data is live in beta, check it out!
Cuprina Holdings (Cayman) Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cuprina Holdings (Cayman) and similar public comparables like Airway Medix, BioRegenx, Etropal, Momina Krepost and more.
Cuprina Holdings (Cayman) Overview
About Cuprina Holdings (Cayman)
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
Founded
2023
HQ
Employees
14
Website
Sectors
Financials (FY)
EV
$5M
Cuprina Holdings (Cayman) Financials
Cuprina Holdings (Cayman) reported last fiscal year revenue of $38K and negative EBITDA of ($1M).
In the same fiscal year, Cuprina Holdings (Cayman) generated ($2K) in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).
Cuprina Holdings (Cayman) P&L
In the most recent fiscal year, Cuprina Holdings (Cayman) reported revenue of $38K and EBITDA of ($1M).
Cuprina Holdings (Cayman) expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $38K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($2K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (6%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (2958%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (3066%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (3230%) | XXX | XXX | XXX |
| Net Debt | — | — | $80K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cuprina Holdings (Cayman) Stock Performance
Cuprina Holdings (Cayman) has current market cap of $8M, and enterprise value of $5M.
Market Cap Evolution
Cuprina Holdings (Cayman)'s stock price is $0.37.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $8M | 0.0% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCuprina Holdings (Cayman) Valuation Multiples
Cuprina Holdings (Cayman) trades at 126.1x EV/Revenue multiple, and (4.3x) EV/EBITDA.
Cuprina Holdings (Cayman) Financial Valuation Multiples
As of April 2, 2026, Cuprina Holdings (Cayman) has market cap of $8M and EV of $5M.
Equity research analysts estimate Cuprina Holdings (Cayman)'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cuprina Holdings (Cayman) has a P/E ratio of (6.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 126.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.1x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (2015.5x) | XXX | XXX | XXX |
| P/E | — | XXX | (6.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cuprina Holdings (Cayman) Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cuprina Holdings (Cayman) Margins & Growth Rates
Cuprina Holdings (Cayman)'s revenue in the last fiscal year declined by (52%).
Cuprina Holdings (Cayman)'s revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Cuprina Holdings (Cayman) Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (52%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (2958%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2613% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 499% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 3060% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cuprina Holdings (Cayman) Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Airway Medix | XXX | XXX | XXX | XXX | XXX | XXX |
| BioRegenx | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Momina Krepost | XXX | XXX | XXX | XXX | XXX | XXX |
| Odinwell | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cuprina Holdings (Cayman) M&A Activity
Cuprina Holdings (Cayman) acquired XXX companies to date.
Last acquisition by Cuprina Holdings (Cayman) was on XXXXXXXX, XXXXX. Cuprina Holdings (Cayman) acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cuprina Holdings (Cayman)
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCuprina Holdings (Cayman) Investment Activity
Cuprina Holdings (Cayman) invested in XXX companies to date.
Cuprina Holdings (Cayman) made its latest investment on XXXXXXXX, XXXXX. Cuprina Holdings (Cayman) invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cuprina Holdings (Cayman)
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cuprina Holdings (Cayman)
| When was Cuprina Holdings (Cayman) founded? | Cuprina Holdings (Cayman) was founded in 2023. |
| Where is Cuprina Holdings (Cayman) headquartered? | Cuprina Holdings (Cayman) is headquartered in Singapore. |
| How many employees does Cuprina Holdings (Cayman) have? | As of today, Cuprina Holdings (Cayman) has over 14 employees. |
| Who is the CEO of Cuprina Holdings (Cayman)? | Cuprina Holdings (Cayman)'s CEO is Yong Qi David Quek. |
| Is Cuprina Holdings (Cayman) publicly listed? | Yes, Cuprina Holdings (Cayman) is a public company listed on Nasdaq. |
| What is the stock symbol of Cuprina Holdings (Cayman)? | Cuprina Holdings (Cayman) trades under CUPR ticker. |
| When did Cuprina Holdings (Cayman) go public? | Cuprina Holdings (Cayman) went public in 2025. |
| Who are competitors of Cuprina Holdings (Cayman)? | Cuprina Holdings (Cayman) main competitors are Airway Medix, BioRegenx, Etropal, Momina Krepost. |
| What is the current market cap of Cuprina Holdings (Cayman)? | Cuprina Holdings (Cayman)'s current market cap is $8M. |
| What is the current revenue of Cuprina Holdings (Cayman)? | Cuprina Holdings (Cayman)'s last fiscal year revenue is $38K. |
| What is the current EV/Revenue multiple of Cuprina Holdings (Cayman)? | Current revenue multiple of Cuprina Holdings (Cayman) is 126.1x. |
| Is Cuprina Holdings (Cayman) profitable? | No, Cuprina Holdings (Cayman) is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.